The implication of the gut microbiome in heart failure
Heart failure is a worldwide health problem with important consequences for the overall
wellbeing of affected individuals as well as for the healthcare system. Over recent decades …
wellbeing of affected individuals as well as for the healthcare system. Over recent decades …
NSAID–gut microbiota interactions
Nonsteroidal anti-inflammatory drugs (NSAID) s relieve pain, inflammation, and fever by
inhibiting the activity of cyclooxygenase isozymes (COX-1 and COX-2). Despite their clinical …
inhibiting the activity of cyclooxygenase isozymes (COX-1 and COX-2). Despite their clinical …
Current knowledge on non-steroidal anti-inflammatory drug-induced small-bowel damage: a comprehensive review
Recent advances in small-bowel endoscopy such as capsule endoscopy have shown that
non-steroidal anti-inflammatory drugs (NSAIDs) frequently damage the small intestine, with …
non-steroidal anti-inflammatory drugs (NSAIDs) frequently damage the small intestine, with …
Soluble fibre supplementation with and without a probiotic in adults with asthma: A 7-day randomised, double blind, three way cross-over trial
Background Soluble fibre modulates airway inflammation in animal models. The aim of this
study was to investigate the effects of soluble fibre supplementation, with and without a …
study was to investigate the effects of soluble fibre supplementation, with and without a …
Bifidobacterium dentium-derived y-glutamylcysteine suppresses ER-mediated goblet cell stress and reduces TNBS-driven colonic inflammation
Endoplasmic reticulum (ER) stress compromises the secretion of MUC2 from goblet cells
and has been linked with inflammatory bowel disease (IBD). Although Bifidobacterium can …
and has been linked with inflammatory bowel disease (IBD). Although Bifidobacterium can …
Pharmacogenomics of NSAID-induced upper gastrointestinal toxicity
Non-steroidal anti-inflammatory drugs (NSAIDs) are a group of drugs which are widely used
globally for the treatment of pain and inflammation, and in the case of aspirin, for secondary …
globally for the treatment of pain and inflammation, and in the case of aspirin, for secondary …
Gut microbiota in NSAID enteropathy: new insights from inside
X Wang, Q Tang, H Hou, W Zhang, M Li… - Frontiers in cellular …, 2021 - frontiersin.org
As a class of the commonly used drugs in clinical practice, non-steroidal anti-inflammatory
drugs (NSAIDs) can cause a series of adverse events including gastrointestinal injuries …
drugs (NSAIDs) can cause a series of adverse events including gastrointestinal injuries …
Contribution of the gut microbiome to drug disposition, pharmacokinetic and pharmacodynamic variability
The trillions of microbes that make up the gut microbiome are an important contributor to
health and disease. With respect to xenobiotics, particularly orally administered compounds …
health and disease. With respect to xenobiotics, particularly orally administered compounds …
The role of probiotics in children with autism spectrum disorders: A study protocol for a randomised controlled trial
L Zhang, Y Xu, H Li, B Li, G Duan, C Zhu - PLoS One, 2022 - journals.plos.org
Background Autism spectrum disorder (ASD) is a neurological and developmental condition
that begins in infancy or earlier and lasts through the individual's lifetime. The aetiology and …
that begins in infancy or earlier and lasts through the individual's lifetime. The aetiology and …
Gastrointestinal disorders and intestinal bacteria: advances in research and applications in therapy
T Ohkusa, Y Nishikawa, N Sato - Frontiers in Medicine, 2023 - frontiersin.org
Intestinal bacteria coexist with humans and play a role in suppressing the invasion of
pathogens, producing short-chain fatty acids, producing vitamins, and controlling the …
pathogens, producing short-chain fatty acids, producing vitamins, and controlling the …